Login

Ben McMillan, CIO and founder of IDX Digital Assets, discusses market insights in an interview with CNBC. 00:10:00

Share On Facebook Share On Twitter

Ben McMillan, CIO of IDX Digital Assets,

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Dr. Doug Gurr: Bridging Worlds for a Sustainable Future | Doug Gurr - Museum Director of Natural History Museum Consulting
00:10:00
Angela McCaffrey on Strategic Mortgage Planning for Financial Empowerment | DeeDee Baze - CEO of Alphemita Financial Services
00:10:00
London Security plc was incorporated in 1897 but operated as an engineering company. In the 1980’s, the activity was amended to that of a property investment company | Emmanuel Sebag,Executive Director,London Security Plc
00:10:00
Own capital is able to define and implement its own long-term strategic goals|Robert R. Dyson, Chairman,The Dyson-Kissner-Moran Corporation
00:10:00
Michael Joyce's Winter 2023 Market Outlook | Michael Joyce, President , Agili .
00:10:00
Leading thoughts from Parsons Corp. CEO Chuck Harrington alongside an interview of Steve Jobs.
00:10:00
12 Questions with Veganz Founder and CEO Jan Bredack | Jan Bredack, CEO , Veganz Group AG.
00:10:00
Expansion and Integration Drive Growth for Multi-Brand Franchisor Amidst Strong Interim Results | Stephen Hemsley, CEO, Franchise Brands PLC.
00:10:00
Believes that better health, quality, outcomes and experiences are possible|Lee Shapiro,Managing Partner,7wire Ventures
00:10:00
Cargotec CFO Addresses Investor Queries: Q1 2024 Insights | Mikko Puolakka - CFO of Cargotec
00:00:00
Dr. Richard Lipscombe, Managing Director, Proteomics International Laboratories Lt
00:10:00
Prospect Capital's Growth Strategies and Investment Expertise

© 2026 Nehu